Pfanstiehl

About Pfanstiehl

Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.

We serve such markets as pharmaceutical, biotechnology, veterinary and cosmetics.

With over...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • US
  • 2017
    On CPHI since
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info

Products from Pfanstiehl (3)

  • Cytarabine

    Product Cytarabine

    Pfanstiehl offers a wide range of products which includes cytarabine. Features: it is mainly used in the treatment of acute myeloid leukemia (aml) and acute lymphocytic leukemia (all) and in lymphomas where it is the backbone of induction chemotherapy. Contact us for more information.
  • Decitabine

    Product Decitabine

    Pfanstiehl offers a wide range of products which includes decitabine. Features: it is approved in 2006 by fda for treatment of patients for with myelodysplastic syndromes (mds), a group of diseases of the bone marrow characterized by the production of poorly functioning and immature blood cells. Over time,...
  • Decitabine

    Product Decitabine

    Small molecule API